CIR Affirms Triclosan Safety, Opts For Formaldehyde Re-Review
This article was originally published in The Rose Sheet
The Cosmetic Ingredient Review Expert Panel tackled a number of controversial issues at its Dec. 13-14 meeting in Washington.
You may also be interested in...
The Cosmetic Ingredient Review Expert Panel’s draft ingredient priority list for 2018 review consists of 14 ingredients, including triclosan. At their April meeting, panelists cited the potential for consumer confusion following recent FDA action banning the ingredient’s OTC use in antibacterial soaps, as well as endocrine-disruption concerns voiced by NGOs.
The Cosmetic Ingredient Review Expert Panel will entertain new data regarding the safety of retinol/retinyl palmitate, triclosan and parabens at its next meeting to determine if safety assessments for the ingredients should be re-opened for further review.
Industry has come out against a study exploring the impact of triclosan on cardiac and skeletal muscle function in animals, which they say is a “publicity campaign” and used “unrealistically large” doses of the anti-bacterial ingredient that do not represent real-world conditions. The NIH-funded study prompted investigators to call for a “dramatic reduction” in the ingredient’s use in consumer products.